Overview

Gender

male

Investor Type

Investment Partner

Peter Svennilson is the Managing Partner and Founder of The Column Group, a biotech VC fund based in San Francisco. He has 23 years of experience in corporate finance, investment banking, and venture capital.

He was the founder and a partner of Three Crowns Capital, a leading backer of a new generation of US biotechnology companies. He helped found companies such as Rosetta, PTC, Tercica, and Somalogic. Over the past 12 years he has helped finance and develop biotech companies, including Tularik, Sunesis, Chemocentryx, Infinity, AVEO, Rinat, and FivePrime.

He is currently a Board Director of NGM Biopharmaceuticals, Aragon Pharmaceuticals and PTC Therapeutics and has served on the Boards of Directors of several other biotechnology companies, including Rosetta, Somalogic, and ChemoCentryx.

Before founding Three Crowns Capital, he was the Associate Managing Director of European Investment Banking Origination at Nomura Securities in London. He is currently a trustee for the Institute for Advanced Study in Princeton, New Jersey.